European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
about
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibilityMultiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attackDipyridamole for preventing stroke and other vascular events in patients with vascular diseaseDipyridamole for preventing stroke and other vascular events in patients with vascular diseaseTriflusal for preventing serious vascular events in people at high riskEffects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second StrokesAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeAngioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trialAnticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatranThe Effects of Chunghyul-Dan (A Korean Medicine Herbal Complex) on Cardiovascular and Cerebrovascular Diseases: A Narrative ReviewSecondary stroke prevention: challenges and solutionsTIA Management: Should TIA Patients be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy?Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-AnalysisInterleukin-6 mediates enhanced thrombus development in cerebral arterioles following a brief period of focal brain ischemia.Anti-platelet therapy: phosphodiesterase inhibitors.Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysisCombination antiplatelet therapy in patients with peripheral vascular bypass graftsAntiplatelet agents in atherothrombotic diseasesAntiplatelet therapy in cardiovascular diseaseDipyridamole bioavailability in subjects with reduced gastric acidityAntithrombotic drugs for secondary stroke prophylaxisDeterminants of the interindividual variability in response to antiplatelet drugsPreventable stroke and stroke preventionEffects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitroAntiplatelet agents for secondary prevention of ischemic strokeRationale for the use of platelet aggregation inhibitors in PAD patientsReview of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agentsWhat is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?Ischemic stroke prevention: an update on antiplatelet therapyAntiplatelets in stroke prevention: the MATCH trial. Some answers, many questions and countless perspectivesStroke prevention in the elderlyUpper gastrointestinal bleeding associated with antiplatelet drugsWhat's new in stroke prevention and treatmentAntiplatelet therapy in stroke prevention: present and futureNew modalities and aspects of antiplatelet therapy for stroke preventionRapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke StudyAntithrombotic drugs in secondary stroke prevention among a community dwelling older populationThe platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusionReview article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
P2860
Q21144269-BAAC0CF5-5F5B-49E9-AF29-BAAA7FAB5F6FQ24201386-7F9E539C-DEAD-49C9-A227-F2E8EF1EE5C6Q24243858-21692B49-B648-4388-91DD-70A6CA0A4B52Q24246236-FE0AF656-3348-4ECD-8880-E45D7A99F6A4Q24246399-C185E93F-331D-4A4D-AB57-4342590C8E3DQ24645205-E8783979-F784-4190-91D9-A9A63AF20D83Q24646522-61F3C648-72BA-46E0-84C8-A840EB01D7CAQ24676024-E74A0914-7D60-4577-A7A3-1B6DB39931B1Q24807132-C1EAF49C-F469-449E-B66E-8D72B4307C74Q26747311-72A5CAF6-A818-49D7-9F37-B4C87CB9EA82Q26795568-F5FD110B-D3F7-416C-BD1A-415310E8C04CQ26796466-BDFD087C-BFAF-4264-A947-F87B5D587C81Q26797510-779ADBEC-8D58-4934-A08D-D7112A38545FQ27311353-F6A21B01-8F0F-4A01-A42E-8B8055B592DEQ27687228-D38D96BC-0E0C-49AD-A671-8BC11A703173Q28076042-EF50FE40-410A-4E83-BA41-FE004485857BQ28167367-E52E468A-4125-4A1C-8177-23CC1F50884EQ28167559-01F8D1FA-2DB0-442F-9AB9-6722753EEA4DQ28167737-7C9D0520-619C-4788-944E-890F20A7DA06Q28177095-17E0A789-1B07-4DBB-B128-D788A66D1535Q28182045-EBDABED9-D141-41D8-868E-7829392E4577Q28187591-38F74381-E0D8-4203-8F33-3ED929BE6EC7Q28187602-51903CD6-B694-47F1-83CD-55D833364B73Q28189188-A01E259C-318A-42CC-805D-00456B2C49A9Q28190669-31D84ABD-E8E0-421F-B17F-ED147092DB70Q28192093-44939EEE-BA8F-4FEB-9B3F-F8471408B3DAQ28192470-B732D2CE-BEE2-4161-B9F3-2426C45E9996Q28192878-94A53677-2123-4632-AB01-0294D5800B0FQ28193224-E133EBAF-78AB-4450-BA75-769278701700Q28193752-C2C6EC0F-54B9-4899-9BB5-02D8B8319380Q28194281-1A3108B5-2DCE-4BA7-B593-6ED36FFF5E70Q28194354-FDF86162-B8AC-4323-919D-B8BF554CC238Q28194923-80D9D538-20A7-44B6-A616-73E114D14A1EQ28195034-7423A5E1-3F44-44BC-A8C0-274E4588F016Q28195042-3EE184B6-CCDD-4AB5-85CF-5A134606ADCCQ28195545-1A631896-0526-4DEE-A709-D756DDE91EDCQ28196133-97D848D4-33CC-4733-B7F3-32B35C45488CQ28196830-A01CB8FB-3D37-4F55-9E2A-AD2788E156A8Q28199545-28ACBB85-359A-486B-AD90-10DDBDFB79F2Q28200403-5188FC39-3D01-4AC0-8D6D-9A64C51D75CD
P2860
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
European Stroke Prevention Stu ...... econdary prevention of stroke.
@en
European Stroke Prevention Stu ...... econdary prevention of stroke.
@nl
type
label
European Stroke Prevention Stu ...... econdary prevention of stroke.
@en
European Stroke Prevention Stu ...... econdary prevention of stroke.
@nl
prefLabel
European Stroke Prevention Stu ...... econdary prevention of stroke.
@en
European Stroke Prevention Stu ...... econdary prevention of stroke.
@nl
P2093
P1476
European Stroke Prevention Stu ...... econdary prevention of stroke.
@en
P2093
P356
10.1016/S0022-510X(96)00308-5
P577
1996-11-01T00:00:00Z